Monday, November 16, 2026AboutTipsSubscribe free
Media Mogul News
INDEPENDENT. UNBOUGHT. UNAFRAID.
LATEST
Cannabis

Trulieve Swings To A Profit And Files 206 DEA Applications In A Single Quarter

The Florida cannabis giant posted net income of 2 million dollars, generated 42 million in free cash flow, and moved fast to cash in on federal rescheduling.

Trulieve Swings To A Profit And Files 206 DEA Applications In A Single Quarter

Trulieve Cannabis just showed Wall Street what a cannabis company looks like when the federal government finally stops strangling the industry. The Florida based operator reported first quarter 2026 revenue of 287 million dollars and net income of 2 million dollars, a dramatic turnaround from a 33 million dollar loss in the same quarter last year.

Revenue actually slipped 4 percent from a year ago, and gross margin came in at 59 percent, down from 62 percent. Adjusted EBITDA landed at 100 million dollars, a 35 percent margin, down from 109 million a year earlier. So this was not a blowout growth quarter. It was something arguably more important for an industry that has burned cash for years: a demonstration of discipline.

The cash numbers tell that story. Trulieve generated 56 million dollars in operating cash flow and 42 million in free cash flow, ending the quarter with 353 million dollars in cash. The company also raised 60 million through a private placement of senior secured notes due 2030. Adjusted net income came in at 20 million dollars.

Get the stories they're afraid to run — free. Join the newsletter →

On the ground, Trulieve opened seven new stores in the quarter and now operates 240 dispensaries with more than 4 million square feet of cultivation and processing capacity. Its customer loyalty program crossed one million members.

The most interesting number in the release has nothing to do with retail. Following the April reclassification of state licensed medical marijuana to Schedule III, Trulieve filed 206 dispensary applications with the DEA. That is a company sprinting through a door the federal government just opened, positioning itself for whatever comes next in federal reform.

CEO Kim Rivers made no secret of where she thinks the credit belongs. She said the company applauds President Trump and Attorney General Blanche for taking bold, decisive action to reclassify medical marijuana to Schedule III. Rivers has been one of the loudest voices in the industry pushing for exactly this outcome, and her company operates the largest medical cannabis footprint in Florida.

What the release did not include is worth noting too. Trulieve issued no forward guidance and offered no specific commentary on how Schedule III treatment will change its 280E tax burden, the punitive federal rule that has forced cannabis companies to pay taxes on gross profit rather than net income. For medical operators, rescheduling opens the door to normal business deductions, and possibly retrospective relief, which could be worth enormous sums to a company of Trulieve's size.

The takeaway for the industry is simple. Legal cannabis can be a profitable, cash generating business even under a hostile tax code and patchwork regulation. Imagine what it looks like when Washington finishes the job.

Sources

Questions readers ask

What is Media Mogul News?

Media Mogul News is an independent, reader-supported news site led by Chief Editor Nate Jurewicz. We cover the stories corporate media skips: political corruption, Big Pharma, the deep state, election integrity, cannabis freedom, crypto and the money behind all of it.

What is your political stance?

We are pro-liberty, pro-cannabis, anti-war and anti-corruption, and we hold both parties to the same standard. We are not a party outlet. When the people we agree with get something wrong, we say so.

How is Media Mogul funded?

By readers. We take no pharmaceutical advertising and no money from the industries we cover. Support comes from newsletter readers, donations and Media Mogul merchandise.